Anal cancer: leading the way

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorHABR-GAMA, Angelita
dc.contributor.authorJULIAO, Guilherme Pagin Sao
dc.contributor.authorPEREZ, Rodrigo Oliva
dc.date.accessioned2017-06-09T15:33:23Z
dc.date.available2017-06-09T15:33:23Z
dc.date.issued2017
dc.description.indexMEDLINE
dc.identifier.citationLANCET ONCOLOGY, v.18, n.3, p.276-277, 2017
dc.identifier.eissn1474-5488
dc.identifier.issn1470-2045
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/20040
dc.language.isoeng
dc.publisherELSEVIER SCIENCE INC
dc.relation.ispartofLancet Oncology
dc.rightsrestrictedAccess
dc.rights.holderCopyright ELSEVIER SCIENCE INC
dc.subject.otherrectal-cancer
dc.subject.otherchemoradiation
dc.subject.otherchemotherapy
dc.subject.othercarcinomas
dc.subject.othertherapy
dc.subject.wosOncology
dc.titleAnal cancer: leading the way
dc.typearticle
dc.type.categoryeditorial material
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.author.externalJULIAO, Guilherme Pagin Sao:Angelita & Joaquim Gama Inst, Dept Gastroenterol, BR-04001005 Sao Paulo, Brazil
hcfmusp.citation.scopus2
hcfmusp.contributor.author-fmusphcANGELITA HABR GAMA
hcfmusp.contributor.author-fmusphcRODRIGO OLIVA PEREZ
hcfmusp.description.beginpage276
hcfmusp.description.endpage277
hcfmusp.description.issue3
hcfmusp.description.volume18
hcfmusp.origemWOS
hcfmusp.origem.pubmed28209297
hcfmusp.origem.scopus2-s2.0-85012024086
hcfmusp.origem.wosWOS:000396344600027
hcfmusp.publisher.cityNEW YORK
hcfmusp.publisher.countryUSA
hcfmusp.relation.referenceAllal AS, 1999, BRIT J CANCER, V80, P1588, DOI 10.1038/sj.bjc.6990567
hcfmusp.relation.referenceBenson A, 2012, J NATL COMPR CANC NE, V10, P449
hcfmusp.relation.referenceDeniaud-Alexandre E, 2003, INT J RADIAT ONCOL, V56, P1259, DOI 10.1016/S0360-3016(03)00417-6
hcfmusp.relation.referenceGlynne-Jones R, 2017, LANCET ONCOL
hcfmusp.relation.referenceHabr-Gama A, 2004, ANN SURG, V240, P711, DOI 10.1097/01.sla.0000141194.27992.32
hcfmusp.relation.referenceJames RD, 2013, LANCET ONCOL, V14, P516, DOI 10.1016/S1470-2045(13)70086-X
hcfmusp.relation.referenceNIGRO ND, 1974, DIS COLON RECTUM, V17, P354, DOI 10.1007/BF02586980
hcfmusp.relation.referencePerez RO, 2016, LANCET ONCOL, V17, P125, DOI 10.1016/S1470-2045(15)00487-8
hcfmusp.relation.referenceRenehan AG, 2016, LANCET ONCOL, V17, P174, DOI 10.1016/S1470-2045(15)00467-2
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublication2ad6fd55-1212-4806-aec6-ad58c73f2ad6
relation.isAuthorOfPublication8f371ba7-6056-4193-adf1-6dcc1caea9d6
relation.isAuthorOfPublication.latestForDiscovery2ad6fd55-1212-4806-aec6-ad58c73f2ad6
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_HABR-GAMA_Anal_cancer_leading_the_way_2017.PDF
Tamanho:
215.81 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)